Apeloa Pharmaceutical News

Pro-Pharmaceuticals: Announcement on Obtaining a Drug Registration Certificate

Dec 10 00:00

Proglo Pharmaceutical: Announcement on the progress of guarantees for subsidiary companies

Nov 30 00:00

Pro-Pharmaceuticals: Announcement on Obtaining a Drug Registration Certificate

Nov 26 00:00

Pro-Pharmaceuticals: Announcement on Obtaining a Drug Registration Certificate

Nov 12 00:00

Proglo Pharmaceutical: Announcement on the progress of guarantees for subsidiary companies

Nov 1 00:00

Prologis Pharmaceuticals: Investor Relations Activity Record Form for October 18, 2024

Oct 20 10:40

Prologis Pharmaceuticals: Announcement on amantadine hydrochloride tablets being approved for marketing by the US FDA

Oct 9 00:00

Proglo Pharmaceutical: Announcement on the progress of guarantees for subsidiary companies

Oct 8 00:00

Proglo Pharmaceutical: Announcement on the progress of guarantees for subsidiary companies

Aug 31 00:00

Apeloa Pharmaceutical: Investor relations activity record form for August 16, 2024.

Aug 19 08:42

Apeloa Pharmaceutical: Announcement on Progress Made Regarding Guarantees for Subsidiary Companies.

Aug 1 00:00

Apeloa Pharmaceutical: Announcement on Progress Made Regarding Guarantees for Subsidiary Companies.

Jun 29 00:00

Apeloa Pharmaceutical: Announcement on the progress of guarantees for subsidiary companies

Jun 1 00:00

Prologis Pharmaceuticals: Investor Relations Activity Record Form for April 18, 2024

Apr 19 13:27

Propulo Pharmaceutical: Announcement of Resolutions of the 6th Meeting of the 9th Board of Directors

Apr 10 00:00

Proglo Pharmaceutical: Announcement on the progress of guarantees for subsidiary companies

Mar 30 00:00

Propulo Pharmaceutical: Announcement of Resolutions of the Fifth Meeting of the 9th Board of Directors

Mar 28 00:00

Prologis Pharmaceuticals: Investor Relations Activity Record Form for March 21, 2024

Mar 22 08:31

Prologis Pharmaceuticals: Announcement on holding an online performance briefing for the 2023 Annual Report

Mar 9 00:00

Pro-Pharmaceutical:000739 Pro-PharmaceuticalInvestor Relations Management Information 20240308

Mar 8 20:21